Expedeon (now part of Abcam)
Biotechnology ResearchEngland, United Kingdom2-10 Employees
We are now part of Abcam and will shortly be closing this account. Follow Abcam for the latest news and information. See you there!
Strategic Acquisition As part of Abcam following its acquisition of MarkerGene Technologies, the company is expanding its product offerings and scientific capabilities, presenting opportunities to introduce complementary laboratory and research solutions.
Innovation Focus Recent product launches like the SimpleStep Ignite ELISA platform highlight Abcam's commitment to cutting-edge assay technologies, indicating a potential demand for advanced laboratory instrumentation and automation solutions.
Financial Landscape With annual revenues under 1 million dollars and recent funding of 6.5 million dollars, the company is positioned for growth and may be receptive to investment in scalable R&D tools and supply chain enhancements.
Leadership Transitions Frequent executive changes, including new appointments of leaders like Markus Lusser, suggest a dynamic strategic direction that offers an opening to provide executive-level solutions or consulting services to support organizational growth.
Technological Integration Utilizing a tech stack including Docker, Grafana, and cloud-based advertising tools, the company displays a modern, digital-first approach, indicating potential opportunities for advanced data analytics, cloud infrastructure, and marketing technology solutions.
Expedeon (now part of Abcam) uses 8 technology products and services including Google AdWords, Grafana, Docker, and more. Explore Expedeon (now part of Abcam)'s tech stack below.
| Expedeon (now part of Abcam) Email Formats | Percentage |
| First.Last@expedeon.com | 73% |
| Last@expedeon.com | 18% |
| First@expedeon.com | 9% |
| First.Last@abcam.com | 88% |
| FLast@abcam.com | 11% |
| First.L@abcam.com | 1% |
Biotechnology ResearchEngland, United Kingdom2-10 Employees
We are now part of Abcam and will shortly be closing this account. Follow Abcam for the latest news and information. See you there!
Expedeon (now part of Abcam) has raised a total of $6.5M of funding over 2 rounds. Their latest funding round was raised on Aug 30, 2018 in the amount of $6.5M.
Expedeon (now part of Abcam)'s revenue is estimated to be in the range of $1M
Expedeon (now part of Abcam) has raised a total of $6.5M of funding over 2 rounds. Their latest funding round was raised on Aug 30, 2018 in the amount of $6.5M.
Expedeon (now part of Abcam)'s revenue is estimated to be in the range of $1M